Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
28.62
-1.31 (-4.38%)
At close: Jun 5, 2026, 4:00 PM EDT
28.39
-0.23 (-0.80%)
After-hours: Jun 5, 2026, 6:58 PM EDT
Celldex Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Reiterates $38 → $54 | Buy | Reiterates | $38 → $54 | +88.68% | May 13, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $67 | Buy | Reiterates | $67 | +134.10% | May 8, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $34 → $38 | Hold | Maintains | $34 → $38 | +32.77% | May 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $62 | Buy | Maintains | $62 | +116.63% | May 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $42 | Buy | Reiterates | $42 | +46.75% | May 8, 2026 |
| Barclays | Barclays | Buy Reiterates $45 → $48 | Buy | Reiterates | $45 → $48 | +67.71% | May 8, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 8, 2026 |
| Wolfe Research | Wolfe Research | Buy Upgrades $44 | Buy | Upgrades | $44 | +53.74% | Mar 23, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.